We are live on
!
Find out more
CIAM
Caitong International Asset Management Portfolio holdings
AUM
$729M
1-Year Est. Return
1,176.98%
This Fund
S&P 500
This Quarter
Est. Return
+11.82%
1 Year Est. Return
+1,176.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$408M
AUM Growth
+$264M
(+183%)
Cap. Flow
+$290M
Cap. Flow
% of AUM
71.11%
Top 10 Holdings %
Top 10 Hldgs %
42.15%
Holding
2,498
New
625
Increased
740
Reduced
453
Closed
660
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ondas Inc
ONDS
|
+$27.5M |
| 2 |
Tesla
TSLA
|
+$21.2M |
| 3 |
Corcept Therapeutics
CORT
|
+$19.8M |
| 4 |
Micron Technology
MU
|
+$18.6M |
| 5 |
Rocket Lab Corp
RKLB
|
+$17.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$8.84M |
| 2 |
Wolfspeed
WOLF
|
+$6.68M |
| 3 |
IonQ
IONQ
|
+$4.85M |
| 4 |
Rigetti Computing
RGTI
|
+$3.55M |
| 5 |
Intel
INTC
|
+$3.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.96% |
| 2 | Financials | 15.19% |
| 3 | Consumer Discretionary | 13.61% |
| 4 | Industrials | 13.03% |
| 5 | Healthcare | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Maravai LifeSciences
MRVI
$861M
| $15.3K | ﹤0.01% |
+4,719
| New | +$15.9K |
|
1052
Sony
SONY
$138B
| $15.3K | ﹤0.01% |
598
-133
| -18% | -$3.73K |
|
1053
Sonos
SONO
$1.96B
| $15.1K | ﹤0.01% |
+861
| New | +$15K |
|
1054
Arbutus Biopharma
ABUS
$906M
| $15.1K | ﹤0.01% |
+3,134
| New | +$14.1K |
|
1055
Central Pacific Financial
CPF
$1B
| $15.1K | ﹤0.01% |
483
-150
| -24% | -$4.52K |
|
1056
Tenable Holdings
TENB
$4.41B
| $15K | ﹤0.01% |
+639
| New | +$17.5K |
|
1057
Douglas Dynamics
PLOW
$967M
| $14.9K | ﹤0.01% |
457
+455
| +22,750% | +$14.4K |
|
1058
Stevanato
STVN
$5.88B
| $14.8K | ﹤0.01% |
+737
| New | +$17.1K |
|
1059
LeMaitre Vascular
LMAT
$1.87B
| $14.8K | ﹤0.01% |
182
+154
| +550% | +$13.3K |
|
1060
Progress Software
PRGS
$1.83B
| $14.7K | ﹤0.01% |
343
-6
| -2% | -$262 |
|
1061
3M
MMM
$94.2B
| $14.7K | ﹤0.01% |
92
+74
| +411% | +$12.1K |
|
|
THR
1062
DELISTED
Thermon Group Holdings
THR
| $14.7K | ﹤0.01% |
+396
| New | +$13K |
|
1063
RenaissanceRe
RNR
$13.3B
| $14.6K | ﹤0.01% |
52
+44
| +550% | +$11.6K |
|
1064
Millicom
TIGO
$15.8B
| $14.6K | ﹤0.01% |
263
+66
| +34% | +$3.32K |
|
1065
Hershey
HSY
$37.4B
| $14.6K | ﹤0.01% |
+80
| New | +$14.6K |
|
1066
Advance Auto Parts
AAP
$3.46B
| $14.5K | ﹤0.01% |
370
-131
| -26% | -$6.57K |
|
1067
Enliven Therapeutics
ELVN
$4.25B
| $14.5K | ﹤0.01% |
940
+932
| +11,650% | +$18.6K |
|
1068
10x Genomics
TXG
$7.58B
| $14.4K | ﹤0.01% |
883
-483
| -35% | -$7.3K |
|
1069
Goosehead Insurance
GSHD
$2.39B
| $14.3K | ﹤0.01% |
194
-117
| -38% | -$8.34K |
|
1070
Alpha Metallurgical Resources
AMR
$1.97B
| $14.2K | ﹤0.01% |
71
+19
| +37% | +$3.28K |
|
1071
Omnicom Group
OMC
$24.2B
| $14.1K | ﹤0.01% |
175
+108
| +161% | +$8.25K |
|
|
NLOP
1072
Net Lease Office Properties
NLOP
$173M
| $14K | ﹤0.01% |
543
+466
| +605% | +$13.2K |
|
1073
Avnet
AVT
$7.87B
| $14K | ﹤0.01% |
+291
| New | +$14.3K |
|
|
MRP
1074
Millrose Properties Inc
MRP
$5.02B
| $14K | ﹤0.01% |
468
-855
| -65% | -$26.8K |
|
1075
AbCellera Biologics
ABCL
$3.36B
| $14K | ﹤0.01% |
+4,082
| New | +$18.2K |
|
Similar funds
GIC
GFI
TC
FAN
VCM
FIS
KC
AIM
Caitong International Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Caitong International Asset Management held 2,498 positions worth $408M, up 183% from $144M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Caitong International Asset Management deployed $290M of net new capital in Q4 2025, opening 625 new positions and adding to 740 existing holdings. Its largest new stake was Corcept Therapeutics: 251,632 shares worth $8.76M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 44% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $8.84M trimmed.
- Caitong International Asset Management's largest Q4 2025 buy was Corcept Therapeutics: 251,632 shares worth $8.76M.
- Caitong International Asset Management added most to Ondas Inc in Q4 2025, an estimated $27.5M increase.
- Caitong International Asset Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $8.84M.
- Caitong International Asset Management fully exited Tilray in Q4 2025, selling an estimated $1.72M.
- Caitong International Asset Management's ten largest holdings make up 42% of its $408M portfolio in Q4 2025.
- Caitong International Asset Management opened 625 new positions and closed 660 in Q4 2025.
- Caitong International Asset Management's portfolio value rose 183% quarter-over-quarter to $408M.
Based on Caitong International Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.